Multiple investigations have documented the correlation between the expression of programmed death-ligand 1 (PD-L1) and driver mutations in NSCLC; nevertheless, the findings exhibit contradictoriness (10, 99–102). This evidence concerns the gene CD274 and non-small cell lung carcinoma.